Back to discover
Drug

Propofol

Approved · FDA
Emerging researchLate-stage developmentSteady momentum
Also known as Diprivan, Propovan, Propoven, Propoflo+3 more

Diprivan, Propovan, Propoven, Propoflo, 2,6-Diisopropylphenol, 2,6-bis(1-methylethyl)phenol, Propofolum.

4
Research papers
17
Active clinical trials
1
Regulatory events
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Approval: PROPOFOL (ANDA220857)

Regulatory2026-07-14FDA

Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration (SERENE)

Clinical trial2026-07-01Primary completion · ClinicalTrials.gov

Randomized clinical trial of the effect of supplemental opioids in procedural sedation with propofol on serum catecholamines.

Research2013-04-01Academic emergency medicine : official journal of the Society for Academic Emergency Medicine

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Propofol
Aliases & brands
DiprivanPropovanPropovenPropoflo2,6-Diisopropylphenol2,6-bis(1-methylethyl)phenolPropofolum
RxNorm CUI
8782
ChEMBL ID
CHEMBL526
UNII
YI7VU623SF
Regulatory jurisdictions
fda

Regulatory timeline

1 event

The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.

Earliest approval
2026-07-14
Latest approval
2026-07-14
Authorities
FDA
Total events
1
fdaU.S. Food and Drug Administration· 1 event
2026-07-14Approval
Approval: PROPOFOL (ANDA220857)
Evidence ↗

Data from the U.S. Food and Drug Administration (U.S. Food and Drug Administration), public domain (CC0).

Clinical trials

189 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
189
registered trials across all phases
LATEST COMPLETION 2026
17
Active studies
14
Recruiting
162
Late-stage (III+)
107
Completed
65
Discontinued
PHASE DISTRIBUTIONn = 189
Early Phase 14Phase 17Phase 1 / 23Phase 213Phase 2 / 31Phase 320Phase 457Phase N / A84

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

4 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20002015
Most influential
Major research themes6
Anesthesia, Intravenous1Anesthetics, Intravenous1Duodenoscopy1Electroencephalography1Esophagoscopy1Propofol1
Journals, researchers & institutions
Top journals
  • Academic emergency medicine : official journal of the Society for Academic Emergency Medicine1
  • Acta anaesthesiologica Scandinavica1
  • Paediatric anaesthesia1
  • Psychiatry research1
Leading researchers
  • Giesecke AH1
  • Glynn S1
  • Gray RO1
  • Gunter J1
  • Ho JD1
  • Hoffmann C1
  • Hossain MM1
  • Kibelbek MJ1
Leading institutions
free-text, unnormalised
  • Cincinnati Children's Hospital Medical Center1
  • Cincinnati Children's Medical Center1
  • Hennepin County Medical Center1
  • Loma Linda University1
  • University of Hirosaki School of Medicine1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials
  • Regulatory event sources are credited in the Regulatory Timeline above.